High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?
Identifieur interne : 002326 ( Main/Exploration ); précédent : 002325; suivant : 002327High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?
Auteurs : J. De Pedro-Cuesta [Suède, Espagne] ; I. J. Petersen ; L. Stawiarz [Suède] ; G. Gudmundsson ; G. Gudmundsson ; J. Almazán [Espagne] ; H. Tulinius [Islande] ; H. Johansson [Suède]Source :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 1995-02.
English descriptors
- KwdEn :
Abstract
We evaluated levodopa use (LDU) by the Icelandic population focusing on: 1) annual gross levodopa (LD) sales from wholesalers to pharmacies for the period 1978–1990, using a reported method; 2) data from a prescription survey conducted from October 1st, 1990 to March 31st, 1991; and 3) raw and reported data on prevalences of Parkinson's disease (PD) in 1963 in this country. The standard for adjustments and reference population for LDU comparisons was the Swedish in 1984. Crude gross sales of LD in Iceland in 1990 and in Sweden in 1984 amounted to 1.67 and 1.35 DDD/1000 person days respectively. After respective adjustments for age, and for age and the infant mortality rates, taken as an indicator of health care quality, LDU in Iceland in 1990 was found to be 1.82 and 1.63 (95% CI 1.47–1.89) times that for Sweden. Prevalences of LD‐prescription recipients in 1990–1991 and of PD in 1963 increased with age: however, those of drug users were higher than those of PD among the elderly. Higher‐than‐expected prevalences of PD and LD‐prescription users (there being a partial overlap between these two categories) were found in periodically‐clustered, one‐year birth cohorts. These results support the notion that Iceland has a high LDU and suggest that this variation is due to a high prevalence of LD responsive disorders. Cohorts born after registered whooping cough outbreaks in Iceland may account for the magnitude and birth‐related pattern of PD prevalences and LDU levels.
Url:
DOI: 10.1111/j.1600-0404.1995.tb00412.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?</title><author><name sortKey="De Pedro Uesta, J" sort="De Pedro Uesta, J" uniqKey="De Pedro Uesta J" first="J." last="De Pedro-Cuesta">J. De Pedro-Cuesta</name></author><author><name sortKey="Petersen, I J" sort="Petersen, I J" uniqKey="Petersen I" first="I. J." last="Petersen">I. J. Petersen</name></author><author><name sortKey="Stawiarz, L" sort="Stawiarz, L" uniqKey="Stawiarz L" first="L." last="Stawiarz">L. Stawiarz</name></author><author><name sortKey="Gudmundsson, G" sort="Gudmundsson, G" uniqKey="Gudmundsson G" first="G." last="Gudmundsson">G. Gudmundsson</name></author><author><name sortKey="Gudmundsson, G" sort="Gudmundsson, G" uniqKey="Gudmundsson G" first="G." last="Gudmundsson">G. Gudmundsson</name></author><author><name sortKey="Almazan, J" sort="Almazan, J" uniqKey="Almazan J" first="J." last="Almazán">J. Almazán</name></author><author><name sortKey="Tulinius, H" sort="Tulinius, H" uniqKey="Tulinius H" first="H." last="Tulinius">H. Tulinius</name></author><author><name sortKey="Johansson, H" sort="Johansson, H" uniqKey="Johansson H" first="H." last="Johansson">H. Johansson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9AB4816873B83723C60EAA7F2FB3B278BE2875D9</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1111/j.1600-0404.1995.tb00412.x</idno><idno type="url">https://api.istex.fr/document/9AB4816873B83723C60EAA7F2FB3B278BE2875D9/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002A13</idno><idno type="wicri:Area/Main/Curation">002658</idno><idno type="wicri:Area/Main/Exploration">002326</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?</title><author><name sortKey="De Pedro Uesta, J" sort="De Pedro Uesta, J" uniqKey="De Pedro Uesta J" first="J." last="De Pedro-Cuesta">J. De Pedro-Cuesta</name><affiliation wicri:level="1"><country xml:lang="fr">Suède</country><wicri:regionArea>Unit for Neuroepidemiology Division of Neurology, Huddinge University Hospital, Karolinska Institute</wicri:regionArea><wicri:noRegion>Karolinska Institute</wicri:noRegion></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Petersen, I J" sort="Petersen, I J" uniqKey="Petersen I" first="I. J." last="Petersen">I. J. Petersen</name><affiliation><wicri:noCountry code="subField">Ministry of Health</wicri:noCountry></affiliation></author><author><name sortKey="Stawiarz, L" sort="Stawiarz, L" uniqKey="Stawiarz L" first="L." last="Stawiarz">L. Stawiarz</name><affiliation wicri:level="1"><country xml:lang="fr">Suède</country><wicri:regionArea>Unit for Neuroepidemiology Division of Neurology, Huddinge University Hospital, Karolinska Institute</wicri:regionArea><wicri:noRegion>Karolinska Institute</wicri:noRegion></affiliation></author><author><name sortKey="Gudmundsson, G" sort="Gudmundsson, G" uniqKey="Gudmundsson G" first="G." last="Gudmundsson">G. Gudmundsson</name><affiliation><wicri:noCountry code="subField">National University Hospital</wicri:noCountry></affiliation></author><author><name sortKey="Gudmundsson, G" sort="Gudmundsson, G" uniqKey="Gudmundsson G" first="G." last="Gudmundsson">G. Gudmundsson</name><affiliation><wicri:noCountry code="subField">National University Hospital</wicri:noCountry></affiliation></author><author><name sortKey="Almazan, J" sort="Almazan, J" uniqKey="Almazan J" first="J." last="Almazán">J. Almazán</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Tulinius, H" sort="Tulinius, H" uniqKey="Tulinius H" first="H." last="Tulinius">H. Tulinius</name><affiliation wicri:level="1"><country xml:lang="fr">Islande</country><wicri:regionArea>Department of Social and Preventive Medicine, Reykjavik University, Reykjavik</wicri:regionArea><wicri:noRegion>Reykjavik</wicri:noRegion></affiliation></author><author><name sortKey="Johansson, H" sort="Johansson, H" uniqKey="Johansson H" first="H." last="Johansson">H. Johansson</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>National Corporation of Swedish Pharmacies, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1995-02">1995-02</date><biblScope unit="volume">91</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="79">79</biblScope><biblScope unit="page" to="88">88</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">9AB4816873B83723C60EAA7F2FB3B278BE2875D9</idno><idno type="DOI">10.1111/j.1600-0404.1995.tb00412.x</idno><idno type="ArticleID">ANE79</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>drug use</term><term>epidemiology</term><term>etiology</term><term>levodopa</term><term>pertussis</term><term>quality assessment</term><term>therapy</term><term>whooping cough</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We evaluated levodopa use (LDU) by the Icelandic population focusing on: 1) annual gross levodopa (LD) sales from wholesalers to pharmacies for the period 1978–1990, using a reported method; 2) data from a prescription survey conducted from October 1st, 1990 to March 31st, 1991; and 3) raw and reported data on prevalences of Parkinson's disease (PD) in 1963 in this country. The standard for adjustments and reference population for LDU comparisons was the Swedish in 1984. Crude gross sales of LD in Iceland in 1990 and in Sweden in 1984 amounted to 1.67 and 1.35 DDD/1000 person days respectively. After respective adjustments for age, and for age and the infant mortality rates, taken as an indicator of health care quality, LDU in Iceland in 1990 was found to be 1.82 and 1.63 (95% CI 1.47–1.89) times that for Sweden. Prevalences of LD‐prescription recipients in 1990–1991 and of PD in 1963 increased with age: however, those of drug users were higher than those of PD among the elderly. Higher‐than‐expected prevalences of PD and LD‐prescription users (there being a partial overlap between these two categories) were found in periodically‐clustered, one‐year birth cohorts. These results support the notion that Iceland has a high LDU and suggest that this variation is due to a high prevalence of LD responsive disorders. Cohorts born after registered whooping cough outbreaks in Iceland may account for the magnitude and birth‐related pattern of PD prevalences and LDU levels.</div></front></TEI><affiliations><list><country><li>Espagne</li><li>Islande</li><li>Suède</li></country><region><li>Communauté de Madrid</li><li>Svealand</li></region><settlement><li>Madrid</li><li>Stockholm</li></settlement></list><tree><noCountry><name sortKey="Gudmundsson, G" sort="Gudmundsson, G" uniqKey="Gudmundsson G" first="G." last="Gudmundsson">G. Gudmundsson</name><name sortKey="Gudmundsson, G" sort="Gudmundsson, G" uniqKey="Gudmundsson G" first="G." last="Gudmundsson">G. Gudmundsson</name><name sortKey="Petersen, I J" sort="Petersen, I J" uniqKey="Petersen I" first="I. J." last="Petersen">I. J. Petersen</name></noCountry><country name="Suède"><noRegion><name sortKey="De Pedro Uesta, J" sort="De Pedro Uesta, J" uniqKey="De Pedro Uesta J" first="J." last="De Pedro-Cuesta">J. De Pedro-Cuesta</name></noRegion><name sortKey="Johansson, H" sort="Johansson, H" uniqKey="Johansson H" first="H." last="Johansson">H. Johansson</name><name sortKey="Stawiarz, L" sort="Stawiarz, L" uniqKey="Stawiarz L" first="L." last="Stawiarz">L. Stawiarz</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="De Pedro Uesta, J" sort="De Pedro Uesta, J" uniqKey="De Pedro Uesta J" first="J." last="De Pedro-Cuesta">J. De Pedro-Cuesta</name></region><name sortKey="Almazan, J" sort="Almazan, J" uniqKey="Almazan J" first="J." last="Almazán">J. Almazán</name></country><country name="Islande"><noRegion><name sortKey="Tulinius, H" sort="Tulinius, H" uniqKey="Tulinius H" first="H." last="Tulinius">H. Tulinius</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002326 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002326 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:9AB4816873B83723C60EAA7F2FB3B278BE2875D9
|texte= High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?
}}
| This area was generated with Dilib version V0.6.23. |  |